Skip to content
Health

New From CFR: Thomas Bollyky on Big Data and Global Health

<p>Cancer patients sit in a chemotherapy ward while receiving treatment at the Korle Bu Teaching Hospital in Accra, Ghana on April 24, 2012 (Olivier Asselin/Courtesy Reuters).</p>
Cancer patients sit in a chemotherapy ward while receiving treatment at the Korle Bu Teaching Hospital in Accra, Ghana on April 24, 2012 (Olivier Asselin/Courtesy Reuters).

By experts and staff

Published
  • Development Channel Staff

Last week, CFR senior fellow Thomas Bollyky published an Expert Brief analyzing the impact of the new Global Burden of Disease (GBD) Study, which measures levels of disease and other health phenomena around the world. He argues that while the study is unlikely to shift the priorities of health donors, GBD data can provide useful guidance as countries grapple with the growing threat of noncommunicable diseases. As he writes: